Small-diameter artificial vascular grafts (SDAVG) are used to bypass blood flow in arterial
occlusive diseases such as coronary heart or peripheral arterial disease. However, SDAVGs …

Coronary artery disease (CAD) remains one of the most important causes of morbidity and
mortality worldwide, and the availability of percutaneous or surgical revascularization …

Various perivascular drug delivery techniques have been demonstrated for localized post-
treatment of intimal hyperplasia: a vascular inflammatory response caused by endothelial …

Background The saphenous vein remains the most frequently used conduit for coronary
artery bypass grafting, despite reported unsatisfactory long‐term patency rates …

The relationship between malignancy and coagulopathy is one that is well documented yet
incompletely understood. Clinicians have attempted to quantify the hypercoagulable state …

Coronary artery bypass grafting (CABG) is and continues to be the preferred
revascularization strategy in patients with multivessel disease. Graft selection has been …

Introduction Intimal hyperplasia (IH) is a significant factor limiting the success of
revascularization surgery for blood flow restoration. IH results from a foreign body response …

Introduction: Coronary artery bypass grafting remains one of the best therapies for advanced
coronary artery disease. The most used conduit remains the great saphenous vein, which is …

Background Lack of autologous graft material restricts the ability to treat patients requiring
coronary artery bypass surgery (CABG). An off the shelf tissue engineered small diameter …

The left internal mammary artery (LIMA) is considered the criterion standard vessel for use in
coronary artery bypass grafting. In recent decades, countless studies have documented its …